Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 7.68% | 161.38 | 0.0% | $1898.51m | |
| OCGN | Ocugen, Inc. | 6.32% | 8.75 | 0.0% | $1079.84m | |
| BNTX | BioNTech SE | 6.63% | 192.77 | 0.0% | $872.52m | |
| AMGN | Amgen, Inc. | 0.43% | 251.38 | 1.3% | $740.91m | |
| NVAX | Novavax, Inc. | 8.84% | 131.69 | 79.8% | $572.50m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.26% | 7.68 | 0.7% | $536.86m | |
| GILD | Gilead Sciences, Inc. | -0.55% | 68.53 | 1.0% | $504.56m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.11% | 516.62 | 2.7% | $432.65m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.09% | 173.49 | 2.0% | $412.31m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.28% | 217.09 | 1.9% | $311.54m | |
| ILMN | Illumina, Inc. | 2.03% | 381.03 | 3.5% | $302.74m | |
| BIIB | Biogen, Inc. | -0.53% | 280.21 | 1.7% | $269.43m | |
| VXRT | Vaxart, Inc. | 4.92% | 6.61 | 0.0% | $240.79m | |
| CRSP | CRISPR Therapeutics AG | 5.58% | 106.64 | 0.6% | $171.41m | |
| BNGO | Bionano Genomics, Inc. | 22.45% | 5.40 | 0.0% | $162.77m |
Company Profile
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.